国发股份(600538) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥89,013,382.17, a decrease of 25.30% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2023 was -¥5,976,006.97, representing a decline of 124.77% year-on-year[4]. - The basic earnings per share for Q3 2023 was -¥0.01, a decrease of 120.00% compared to the same period last year[4]. - The weighted average return on equity for Q3 2023 was -0.64%, a decline of 124.90% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was -¥6,179,663.42, down 125.66% year-on-year[4]. - Total operating revenue for the first three quarters of 2023 was CNY 283,265,700.12, a decrease of 16.3% compared to CNY 338,428,175.18 in the same period of 2022[20]. - The net loss for the first three quarters of 2023 was CNY 14,325,113.35, compared to a net profit of CNY 34,258,280.90 in the same period of 2022[21]. - The company's operating profit for the first three quarters of 2023 was a loss of CNY 13,483,108.36, contrasting with an operating profit of CNY 39,664,488.62 in the previous year[20]. - The basic and diluted earnings per share for the first three quarters of 2023 were both CNY -0.03, compared to CNY 0.06 in the same period of 2022[21]. Cash Flow - The cash flow from operating activities for the year-to-date period was -¥18,709,066.34, indicating a significant cash outflow[4]. - The net cash flow from operating activities was -CNY 18,709,066.34, an improvement from -CNY 41,474,329.81 year-over-year[23]. - The cash inflow from operating activities was CNY 300,206,440.60, a decrease of 1.1% compared to CNY 305,263,487.66 in the same period of 2022[23]. - The cash outflow for purchasing goods and services was CNY 220,188,765.71, down 15.9% from CNY 261,787,797.96 in the previous year[23]. - The cash paid for fixed assets and other long-term assets was CNY 7,029,050.24, an increase of 104.5% compared to CNY 3,431,180.38 in the previous year[24]. - The cash received from investment recoveries was CNY 10,000,000.00, marking a new source of cash inflow[24]. - The cash inflow from financing activities was CNY 500,000.00, compared to CNY 5,350,642.30 in the previous year, indicating a significant decrease[24]. - The net cash flow from financing activities was -CNY 1,518,985.93, a decline from CNY 3,863,177.53 year-over-year[24]. - The ending cash and cash equivalents balance was CNY 131,784,881.69, down from CNY 142,872,555.16 at the end of the same period last year[24]. Assets and Liabilities - The total assets at the end of Q3 2023 were ¥1,112,807,351.42, down 2.57% from the end of the previous year[5]. - As of September 30, 2023, the company's total current assets amounted to ¥530,685,864.68, a decrease of 2.6% from ¥543,260,916.19 at the end of 2022[17]. - The total equity attributable to shareholders at the end of Q3 2023 was ¥935,837,067.16, a decrease of 1.65% from the previous year-end[5]. - The total liabilities as of the end of the third quarter of 2023 were CNY 166,652,954.64, down from CNY 182,165,382.12 at the end of 2022[19]. - The company's long-term equity investments decreased to ¥94,359,381.82 from ¥107,817,382.45, representing a decline of approximately 12.5%[17]. - The company's cash and cash equivalents decreased to ¥151,202,833.23 from ¥170,858,268.06, reflecting a decline of approximately 11.5%[17]. - Accounts receivable increased to ¥242,685,221.33, up from ¥223,539,862.24, indicating a growth of about 8.6%[17]. - The company's inventory increased to ¥91,661,162.65 from ¥84,921,944.31, reflecting a growth of approximately 7.5%[17]. - The total amount of other receivables rose to ¥5,353,074.02 from ¥2,714,880.25, marking an increase of about 97.5%[17]. Shareholder Information - The company’s major shareholder, Zhu Rongjuan, holds 17.25% of shares, with 90,400,542 shares frozen and 67,440,000 shares pledged[12]. - The company is currently implementing a share reduction plan by director Wu Peicheng, aiming to reduce up to 1,051,300 shares by January 1, 2024[14]. - The company’s major shareholders include several individuals and entities, with a combined holding of 3.25% by related parties[12]. Investment Income - The company reported a significant decrease in investment income due to a decline in the value of its holdings in the Huada Gongying No. 1 Fund[8]. - The company experienced a decline in investment income, reporting a loss of CNY 14,055,160.37 compared to a gain of CNY 12,522,875.38 in the previous year[20]. - The company completed the transfer of 1% equity in Youfeng Biotechnology for ¥13.2 million, expected to increase current earnings by approximately ¥3.2 million after registration[13].